-
4
-
-
0029739440
-
Drinking, smoking and illicit drug use among 15 and 16 year olds in the United Kingdom
-
McMiller P, Plant M. Drinking, smoking and illicit drug use among 15 and 16 year olds in the United Kingdom. BMJ 1996;313:394-7.
-
(1996)
BMJ
, vol.313
, pp. 394-397
-
-
McMiller, P.1
Plant, M.2
-
7
-
-
0030571203
-
Alcohol and drug use in UK university students
-
Webb E, Ashton CH, Kelly P, et al. Alcohol and drug use in UK university students. Lancet 1996;348:922-5.
-
(1996)
Lancet
, vol.348
, pp. 922-925
-
-
Webb, E.1
Ashton, C.H.2
Kelly, P.3
-
13
-
-
0003326852
-
Adverse psychological effects associated with the use of ecstasy (MDMA), and their treatment
-
Saunders N, ed. Exeter: BPC Wheatons
-
Jansen KLR. Adverse psychological effects associated with the use of ecstasy (MDMA), and their treatment. In: Saunders N, ed. Ecstasy reconsidered. Exeter: BPC Wheatons, 1997: 112-33.
-
(1997)
Ecstasy Reconsidered
, pp. 112-133
-
-
Jansen, K.L.R.1
-
14
-
-
0026680529
-
Toxicity and deaths from 3,4-methylenedioxymethamphetamine
-
Henry J, Jeffreys K, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine. Lancet 1992;340: 384-6.
-
(1992)
Lancet
, vol.340
, pp. 384-386
-
-
Henry, J.1
Jeffreys, K.2
Dawling, S.3
-
15
-
-
0001292410
-
Ecstasy and illegal drug design: A new concept in drug use
-
Forsyth AJM. Ecstasy and illegal drug design: a new concept in drug use. International Journal of Drug Policy 1995;6: 193-209.
-
(1995)
International Journal of Drug Policy
, vol.6
, pp. 193-209
-
-
Forsyth, A.J.M.1
-
18
-
-
0030040183
-
Pathology of deaths associated with "ecstasy" and "eve" misuse
-
Milroy CM, Clark JC, Forrest ARW. Pathology of deaths associated with "ecstasy" and "eve" misuse. J Clin Pathol 1996;49:149-53.
-
(1996)
J Clin Pathol
, vol.49
, pp. 149-153
-
-
Milroy, C.M.1
Clark, J.C.2
Forrest, A.R.W.3
-
22
-
-
0020329077
-
Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans
-
Clements JA, Nimmo WS, Grant IS. Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. J Pharm Sci 1982;71:539-42.
-
(1982)
J Pharm Sci
, vol.71
, pp. 539-542
-
-
Clements, J.A.1
Nimmo, W.S.2
Grant, I.S.3
-
23
-
-
0019470426
-
Pharmacokinetics and analgesic effects of IM and oral ketamine
-
Grant IS, Nimmo WS, Clements JA. Pharmacokinetics and analgesic effects of IM and oral ketamine. Br J Anaesth 1981;53:805-9.
-
(1981)
Br J Anaesth
, vol.53
, pp. 805-809
-
-
Grant, I.S.1
Nimmo, W.S.2
Clements, J.A.3
-
24
-
-
0014964725
-
Ketamine as an induction agent in anaesthetics
-
Dundee JW, Bovill JG, Knox JWD, et al. Ketamine as an induction agent in anaesthetics. Lancet 1970;i:1370-2.
-
(1970)
Lancet
, vol.1
, pp. 1370-1372
-
-
Dundee, J.W.1
Bovill, J.G.2
Knox, J.W.D.3
-
25
-
-
0029846521
-
Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS
-
Helmlin HJ, Bracher K, Bourquin D, et al. Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS. J Anal Toxicol 1996;20:432-40.
-
(1996)
J Anal Toxicol
, vol.20
, pp. 432-440
-
-
Helmlin, H.J.1
Bracher, K.2
Bourquin, D.3
-
26
-
-
0030915543
-
Enantioselective determination of 3,4-methylenedioxymethamphetamine and two of its metabolites in human urine by cyclodextrin-modified capillary zone electrophoresis
-
Lanz M, Brenneisen R, Thormann W. Enantioselective determination of 3,4-methylenedioxymethamphetamine and two of its metabolites in human urine by cyclodextrin-modified capillary zone electrophoresis. Electrophoresis 1997;18:1035-43.
-
(1997)
Electrophoresis
, vol.18
, pp. 1035-1043
-
-
Lanz, M.1
Brenneisen, R.2
Thormann, W.3
|